Cargando…
A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy
Tumor oncogenesis, cancer metastasis, and immune evasion were substantially impacted by the mammalian target of the rapamycin complex 1 (mTORC1) pathway. However, in hepatocellular carcinoma (HCC), no mTORC1 signaling-based gene signature has ever been published. mTORC1 scores were computed employin...
Autores principales: | Chen, Erbao, Mo, Yuqian, Yi, Jing, Liu, Jie, Luo, Ting, Li, Zheng, Lin, Zewei, Hu, Yibing, Zou, Zhilin, Liu, Jikui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497017/ https://www.ncbi.nlm.nih.gov/pubmed/37589508 http://dx.doi.org/10.18632/aging.204862 |
Ejemplares similares
-
Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer
por: Chen, Erbao, et al.
Publicado: (2022) -
A Novel Signature Based on mTORC1 Pathway in Hepatocellular Carcinoma
por: Mo, Zhuomao, et al.
Publicado: (2020) -
Defects in mTORC1 Network and mTORC1-STAT3 Pathway Crosstalk Contributes to Non-inflammatory Hepatocellular Carcinoma
por: Li, Ting, et al.
Publicado: (2020) -
Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
por: Chen, Long, et al.
Publicado: (2015) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)